Phase 2 RCT of 220 children with stage 1 type 1 diabetes: 12 months of high-dose oral insulin did not delay dysglycaemia or diabetes vs placebo (HR 1.07; P=0.74; 5-year progression 40% in each group) or change immune response to insulin.
RCTn = 220
Ziegler et al. Effect of High-Dose Oral Insulin in Children With Stage 1 Type 1 Diabetes: The Fr1da Insulin Intervention Randomized Controlled Trial